Back
asmsPubMedNew toolLong-read sequencing

asms: finding allele-specific methylation in human genomes without phasing.

Raineri E, Esteve Marco MÁ, Casals E, et al.NAR Genom Bioinform 2026 · July 2026
Relevance score
8/10
Disease / domain
Allele-specific methylation detection
Source
PubMed
PMID 42395864
Share on LinkedIn

Tool / method

Tool (asms) identifying allele-specific methylation loci from methylation data without prior phasing, via inter-read methylation heterogeneity

Summary

Allele-specific methylation (ASM) reflects differential methylation between the two alleles, linked to imprinting or genetic variants, and plays a role in gene regulation and disease. Detection methods usually rely on variant-based phasing, computationally intensive and failing in low-heterozygosity regions. The authors develop asms (Allele-Specific Methylation Scanner), which identifies ASM loci without prior phasing by analysing inter-read methylation heterogeneity. Tested on Oxford Nanopore data, it applies to any platform using MM/ML tags and can efficiently scan thousands of loci.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

A clever methodological tool that removes a real constraint — phasing — for allele-specific methylation analysis, relevant notably to imprinting disorders. Its diagnostic added value on real clinical cases beyond technical proof remains to be shown.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 2/3Novelty 2/2Sample 1/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 2/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 8/10

Keywords

long-readallele-specific methylationimprintingphasing-freeNanoporeepigenomics
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime